Equity Details
Price & Market Data
Price: $36.70
Daily Change: +$0.09 / 0.25%
Daily Range: $35.96 - $37.65
Market Cap: $2,634,432,512
Daily Volume: 663,595
Performance Metrics
1 Week: 6.32%
1 Month: -16.04%
3 Months: -16.69%
6 Months: 51.72%
1 Year: 63.18%
YTD: -27.53%
About Vera Therapeutics, Inc. (VERA)
Stay informed with Vera Therapeutics, Inc. (VERA) market data. Current price: 36.70, daily change: +$0.09 / 0.25%. Market cap: 2,634,432,512. Performance over 1-month, 3-month, and 1-year.
Company Details
Employees: 249
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.